CareerCross uses cookies to enhance your experience on our websites. If you continue to view our sites without changing your browser settings, then it iクイーン カジノ 入金 ボーナスssumed that we have your consent to collect and utilise your cookies. If you do not want to give us your consent, then please change the cookie settings on your browser. Please refer to our クイーンカジノ おすすめスロットtion for more information.
CareerCross uses cookies to enhance your experience on our websites. If you continue to view our sites without changing your browser settings, then it iクイーン カジノ 入金 ボーナスssumed that we have your consent to collect and utilise your cookies. If you do not want to give us your consent, then please change the cookie settings on your browser. Please refer to our クイーンカジノ おすすめスロットtion for more information.
SEEDSUPPLY INC. iクイーン カジノ 入金 ボーナス contract research organization, and we have the technology to identify seed compounds that lead to first in class drug.
Service1_Binding compounds screening: HTS for unexplored drug targets that could not be handled by conventional HTS methods (e.g., クイーン カジノ 入金 ボーナスransporter, lysosomal channel) using special binding assay technology and compound library (400K) from Takeda. We can also identify compounds with unique profile (e.g., modulator, PROTAC).
Service2_Binding proteins identification: Identification of the binding proteins of your compounds without any modification using binding assay technology and human protein libraries (18,000 proteins).
Service3_Supply each binder for 200 of GPCRクイーン カジノ 入金 ボーナスnd 100 of SLC transporters.